Skip to content

To compare the efficacy of Janu basti and manual tractions in the management of Janu Sandhigat Vaat w.r.s. Knee Osteoarthritis.

A RANDOMIZED OPEN LEVEL CONTROLLED CLINICAL TRIAL TO ACCESS THE COMPARATIVE EFFICACY OF JANU BASTI IN SANDHIGATAVATA WITH SPECIAL REFERENCE TO OSTEOARTHRITS OF KNEE JOINT

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042466
Enrollment
60
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

national Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: I. Patients between 40-70 years of age. II. Patients with the clinical features of Janu-Sandhigatavata. III. Patients fit for Snehana and Swedana. IV. Patients with radiological findings of Osteoarthritis based on grade 0 to 4 on Kellgren and Lawrence system of classification of Knee OA along with clinical features.VI. Chronicity less than 10 years VII. Patient of either sex between age group of 40-70years having Sandhigat vata (osteoarthritis of Knee joint unilateral and bilateral) , fit for janu basti ? and willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: I. Patient, suffering from any chronic debilitating disease like T.B., D.M., Gout, Varicose veins, Asthma & other chronic problems etc. and having other serious pathology. II. Pregnant women. III. Lactating women. IV. Associated with simple or compound fractures. V. Patients who have developed joint deformity. VI. Patients who have under gone knee replacement surgery. VII. No recent history of meniscal orother knee surgry(less than 6 months)

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Index of osteoarthritis of the knee (womac score). Timepoint: Patient will be acess on baseline day,at the completion of treatment or 4thweek from baseline.

Secondary

MeasureTime frame
I. Pain Visual Analog Scale II. Quality of life assessment through health questionnaire SF12 Timepoint: Patient will be acess on baseline day,at the completion of treatment or 4thweek from baseline

Countries

India

Contacts

Public ContactMini Rathi

National Institute of Ayurveda

sarveshksingh21@gmail.com8739860237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026